MRI 유도하 신경외과 절제 시장 규모, 점유율, 성장 분석 : 제품별, 적응증별, 최종 용도별, 지역별 - 산업 예측(2026-2033년)

MRI-Guided Neurosurgical Ablation Market size was valued at USD 635.43 Million in 2024 and is poised to grow from USD 684.36 Million in 2025 to USD 1238.82 Million by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The MRI-guided neurosurgical ablation market is experiencing robust growth driven by the rising prevalence of nervous system disorders and brain tumors, alongside a shift towards minimally invasive surgical techniques. These approaches are favored by patients due to their potential for quicker recovery and reduced surgical risks, as surgeons utilize specialized instruments to minimize tissue damage. Innovations in real-time, high-resolution MRI have significantly enhanced the precision and safety of these procedures, enabling better visualization and adaptation during surgery. Additionally, advancements such as four-tract tractography are improving treatment capabilities for conditions like medication-resistant tremors. This market growth reflects a growing endorsement from medical professionals who recognize the myriad benefits of minimally invasive techniques over traditional methods in neurosurgery.

Top-down and bottom-up approaches were used to estimate and validate the size of the MRI-Guided Neurosurgical Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

MRI-Guided Neurosurgical Ablation Market Segments Analysis

Global MRI-Guided Neurosurgical Ablation Market is segmented by Product, Indication, End-Use and region. Based on Product, the market is segmented into MRI Guided Laser Ablation Systems, MRI Guided RF Ablation Systems, MRI Guided Focused Ultrasound Systems and Accessories. Based on Indication, the market is segmented into Tumors, Epilepsy, Pain Management and Vascular Malformations. Based on End-Use, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the MRI-Guided Neurosurgical Ablation Market

The growing prevalence of neurological disorders significantly drives the demand for MRI-guided neurosurgical ablation. Various diseases affect the nervous system, leading to conditions that can be life-threatening or result in severe disabilities. As awareness of these disorders rises, so does the need for effective treatment options. Among these, innovative approaches such as MRI-guided neurosurgical ablation are gaining traction, owing to their efficacy and precision in targeting affected areas within the brain. This increased focus on advanced therapeutic techniques reflects a broader trend in healthcare, where cutting-edge technologies are being embraced to enhance patient outcomes and address the complexities of neurological health.

Restraints in the MRI-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market faces significant constraints primarily due to insurance and reimbursement challenges. Although these innovative procedures offer valuable treatment options for individuals with neurological disorders, the variability in insurance coverage and reimbursement policies can create substantial financial obstacles for patients seeking these interventions. In many cases, insurance providers may offer incomplete coverage for the costs associated with MRI-guided neurosurgical ablation, resulting in considerable out-of-pocket expenses for patients, which may deter them from pursuing such treatments. Moreover, the absence of standardized reimbursement practices across different regions and insurance plans complicates the financial landscape, leading to disparities in patient access and potentially hindering the widespread adoption of this advanced technology. Tackling these issues is essential for improving access to MRI-guided neurosurgical ablation and facilitating its integration into conventional healthcare systems.

Market Trends of the MRI-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market is increasingly influenced by the trend of patient-centric care, which prioritizes individualized treatment approaches tailored to each patient's unique needs and preferences. This model enhances the quality of care by focusing on personalized treatment plans that consider the specific medical conditions and characteristics of patients, allowing for minimally invasive and precisely targeted procedures. By fostering a culture of collaboration and shared decision-making, patients become active participants in their healthcare journeys. This emphasis on personalization not only improves patient experiences and satisfaction but also aligns with the overarching shift towards more adaptive and responsive healthcare services within the neurosurgical field, ultimately driving positive clinical outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global MRI-Guided Neurosurgical Ablation Market Size by Product & CAGR (2026-2033)

• Market Overview
• MRI Guided Laser Ablation Systems
• MRI Guided RF Ablation Systems
• MRI Guided Focused Ultrasound Systems
• Accessories

Global MRI-Guided Neurosurgical Ablation Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Tumors
• Epilepsy
• Pain Management
• Vascular Malformations

Global MRI-Guided Neurosurgical Ablation Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global MRI-Guided Neurosurgical Ablation Market Size & CAGR (2026-2033)

• North America (Product, Indication, End-Use)
  • US
  • Canada
• Europe (Product, Indication, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Monteris Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profound Medical Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ClearPoint Neuro, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations